For multivariable Cox regression analysis, we selected established MB features (metastatic disease, LCA histology, STR, sex, i17q, MYCN amplification and CSI dose) as well as biologically and clinically significant molecular factors (WCA status, subgroup 5, subgroup 7, chromosome 13 loss, chromosome 18 gain). This evidence concerns the gene MYCN and metastatic neoplasm.